iX Biopharma
Plaquettes pharmaceutiques sublinguales et produits nutraceutiques.
iX Biopharma fabrique des plaquettes pharmaceutiques sublinguales et des produits nutraceutiques à partir de ses opérations de Singapour. La société fournit des systèmes de santé, des laboratoires, des partenaires OEM ou des clients exportateurs réglementés sur ses principaux marchés cotés.
- Type
- brand seeking distribution
- Location
- Singapore
- Founded
- 2008
- Website
- ixbiopharma.com
- Categories
- Fournitures médicales et de santé, Compléments et bien-être
- Markets
- Singapour, Australie, États-Unis, Royaume-Uni
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- domain-registered (green), checked 2026-08-08 Domain registry record
- sanctions-clear (green), checked 2026-08-08 OpenSanctions
- debarment-clear (green), checked 2026-08-08 OpenSanctions
- certificate-page-on-site (amber), checked 2026-08-11 Company's own certification page
Claimed certifications
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)